GrowGeneration Corp. 2026: Revenue $43.22M, EPS ($0.03) — 10-Q Summary

GrowGeneration Corp. (GRWG) reported for the quarter ended 2026 revenue (net sales) of $43.22M, up from $40.96M, with net loss of $2.01M and diluted EPS of ($0.03), improving versus the prior-year quarter. The company cited higher durable and proprietary brand sales, a mix shift toward durable products, and store consolidation.

Original reporting
Published Aug 11, 2026, 9:31 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 12, 2026, 1:57 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
GrowGeneration Corp. 2026: Revenue $43.22M, EPS ($0.03) — 10-Q Summary — source image
Decision brief

The 30-second read

$GRWGNeutralLow
01

Why it matters

Traders can use the reported revenue growth and improved net loss versus the prior-year quarter as a checkpoint for the company’s turnaround narrative, but the text lacks forward guidance and key profitability/cash-flow metrics.

02

Market read

This is a company-specific earnings-style datapoint from a quarterly filing, but it does not introduce a new catalyst beyond the disclosed results.

03

What to watch

Investors may focus on consumables mix shift (72% cultivation consumables) and the cost savings from closing more than 10 retail locations, but the article does not quantify operating expense or cash flow changes.

Relevance 5/10Novelty 4/10Timing: after-hours filing summary posted Aug. 11, 2026

Background

The article summarizes GrowGeneration Corp.'s SEC 10-Q for the quarter ended 2026, including revenue, net loss, and business highlights.

Company-level read

Ticker impact

$GRWGNeutralMedium confidence
Context

GrowGeneration reported 2026 quarter revenue of $43.22M and diluted EPS of -$0.03, plus net loss of $2.01M, in its 10-Q summary.

Expected impact

Near-term trading impact is likely limited unless investors focus on margin trajectory and whether the right-sizing and brand mix shift can drive sustained profitability.

Evidence & confidence

This is a 10-Q datapoint summary with no guidance, no new deal or regulatory event, and no explicit margin/FCF figures beyond qualitative gross margin improvement.

Market effects

Provides incremental read-through on demand and margin drivers in the cultivation retail and commercial fixture ecosystem.

None specified.

None specified.

Counterpoint

Revenue growth and gross-margin improvement claims may not offset ongoing net losses, so the market may discount the qualitative highlights without hard margin expansion metrics.

Key entities

  • GrowGeneration Corp.

    Subject of the 10-Q summary, reporting $43.22M revenue and -$0.03 diluted EPS for the quarter ended 2026.

Related articles

$GRWGMedAI 8/10

GrowGeneration Beats on Q2 Earnings, Hikes '26 Adjusted EBITDA View

GrowGeneration Corp. (GRWG) reported Q2 2026 results: a 3-cent per-share loss, narrower than the Zacks Consensus estimate of a 4-cent loss and versus an 8-cent loss a year earlier. Sales rose 5.5% to $43.2M. Adjusted EBITDA was $0.3M. The company raised full-year adjusted EBITDA guidance to $2–$3M and reaffirmed sales guidance of $162–$168M.

$GRWGMedAI 8/10

GrowGeneration Corp. Q2 2026 Earnings Call Summary

GrowGeneration Corp. reported a third straight quarter of YoY revenue growth, citing a shift to a commercial B2B platform and proprietary brands. Proprietary brand penetration reached 40% ahead of schedule. The company cut store and operating expenses 22% YoY and raised full-year 2026 adjusted EBITDA guidance to $2M-$3M, aided by expected Q3 IEPA tariff refunds. It repurchased 700,000 shares at $1.38.

$GRWGMedAI 8/10

GrowGeneration (GRWG) Q2 2026 Earnings Call Transcript

GrowGeneration (GRWG) reported Q2 2026 revenue of $43.2 million, up 5.5% year over year, with adjusted EBITDA of $0.3 million versus a $1.3 million loss a year earlier. Net loss narrowed to $2.0 million. Gross margin rose to 28.5%. Full-year 2026 guidance: revenue $162-$168 million and adjusted EBITDA $2-$3 million. Cash was $41 million with no debt.

$MRCYMed

Mercury Systems 3Q 2026: Revenue $253.15M, EPS $0.21 — 10-Q Summary

Mercury Systems reported 3Q 2026 revenue of $253.15M, up 12.4% YoY, and net income of $13.09M, reversing a prior-year loss. Growth in radar and electronic warfare applications drove results, while C4I revenue declined. Gross margin improved to 35.2% from 27.9%. The company expects to recognize 46% of its $1.193B remaining performance obligations as revenue in the next 12 months.

$SNWVMed

Sanuwave Announces Q3 FY2026 Financial Results

SANUWAVE Health, Inc. (SNWV) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Sanuwave Announces Q3 FY2026 Financial Results Q3 2026 revenues were $8.6 million, down 24% from $11.3 million in Q3 2025. Q3 2026 gross margin was 77.3%, versus 77.6% in Q3 2025. GAAP operating loss was $1.1 million for Q3 2026 versus operating income of $0.9 millio

$CPIXHighAI 8/10

CUMBERLAND PHARMACEUTICALS REPORTS Q3 2026 FINANCIAL RESULTS & COMPANY UPDATE

CUMBERLAND PHARMACEUTICALS INC (CPIX) filed an SEC Form 8-K — Results of Operations and Financial Condition. CUMBERLAND PHARMACEUTICALS REPORTS Q3 2026 FINANCIAL RESULTS & COMPANY UPDATE $100 million Strategic Transaction Closed Plans to Submit New Drug Application for Ifetroban in DMD Top-Line Results Announced for Systemic Sclerosis Trial NASHVILLE, Tenn. (Nov. 10, 2026) – Cumberland